Akiko Tanaka

Title: Akiko Tanaka: Innovator in Antithrombotic Research

Introduction

Akiko Tanaka is a prominent inventor based in Kawasaki, Japan. She has made significant contributions to the field of medical research, particularly in the development of substances with antithrombotic activity. With a total of 7 patents to her name, her work has the potential to impact the medical community significantly.

Latest Patents

Among her latest patents is a method for detecting glycokallidin, which facilitates the detection of binding between the von Willebrand factor and glycoprotein Ib. This innovative method involves fixing the von Willebrand factor in a reactor that is immobilized in a reaction vessel in the presence of bottrocetin. The binding occurs with a chimeric protein that is constructed by fusing the carboxyl terminal of a partial protein containing the von Willebrand factor-binding site of glycoprotein Ib with the amino terminal of the Fc region of an immunoglobulin molecule. The detection of the Fc region of the immunoglobulin molecule allows for the identification of the binding between the von Willebrand factor and glycoprotein Ib or the inhibition of this binding.

Career Highlights

Akiko Tanaka is currently employed at Ajinomoto Co., Ltd., where she continues her research and development efforts. Her work is characterized by a commitment to advancing medical science and improving patient outcomes through innovative solutions.

Collaborations

She collaborates with notable colleagues, including Masakazu Sugimoto and Hiroshi Matsui, who contribute to her research endeavors and help drive her projects forward.

Conclusion

Akiko Tanaka's contributions to antithrombotic research and her innovative patents highlight her role as a leading inventor in her field. Her work not only showcases her expertise but also has the potential to make a significant impact on medical practices.